Dr. Koontz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Harris Ct Bld T Ste 201
Monterey, CA 93940Phone+1 831-375-4105
Summary
- Dr. Michael Koontz is an oncologist in Monterey, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care, VA Palo Alto Heath Care, and Community Hospital of the Monterey Peninsula. He received his medical degree from University of California, Irvine, School of Medicine and has been in practice 14 years. He is experienced in general medical oncology. He has 6 publications and over 100 citings.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2010 - 2013
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2007 - 2010
- University of California, Irvine, School of MedicineClass of 2007
Certifications & Licensure
- CA State Medical License 2008 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
- A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer Start of enrollment: 2021 Oct 04
Publications & Presentations
PubMed
- 8 citationsA PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS.Jonathan W. Riess, Nadine Jahchan, Millie Das, M. Zach Koontz, Pamela L. Kunz
Cancer Treatment and Research Communications. 2020-04-20 - 76 citationsRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical TrialsMichael Zach Koontz, Sandra J. Horning, Raymond R. Balise, Peter L. Greenberg, Saul A. Rosenberg
Journal of Clinical Oncology. 2013-02-10 - 13 citationsNelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.Dat Ngo, Samit Patel, Eun-Jeong Kim, Rondeep Brar, Michael Zach Koontz
Journal of Oncology Pharmacy Practice. 2015-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: